ConductScience.org, home

Paper41999560

Survival Impact of Adjuvant Chemotherapy on Stage IB Gastric Cancer Patients After Radical Surgery.

Chen YF and 8 others. J Gastrointest Cancer, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Survival Impact of Adjuvant Chemotherapy on Stage IB Gastric Cancer Patients After Radical Surgery. Papers, record 41999560. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41999560

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Survival Impact of Adjuvant Chemotherapy on Stage IB Gastric Cancer Patients After Radical Surgery.
PubMed
Journal
J Gastrointest Cancer
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-03
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen YFYi-Fu
2Kou HWHao-Wei
3Chen THTsung-Hsing
4Le PHPuo-Hsien
5Kuo CJChia-Jung
6Wang SYShang-Yu
7Chou WCWen-Chi
8Yeh TSTa-Sen
9Hsu JTJun-Te

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Stomach NeoplasmsMajor topic
GastrectomyMajor topic
Neoplasm Recurrence, LocalMajor topic
Humans
Chemotherapy, Adjuvant
Female
Retrospective Studies
Neoplasm Staging
Male
Middle Aged
Aged
Survival Rate

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CMRPG3I0103Chang Gung Medical Research Program, TaiwanPubMed

Source PubMed

Download CSV of grants

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135743747Prognostic Significance of Perineural Invasion in Patients with Stage II/III Gastric Cancer Undergoing Radical Surgery.J Pers Med2022https://conductscience.org/library/papers/35743747PubMed
217978289Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.N Engl J Med2007https://conductscience.org/library/papers/17978289PubMed
333336033Prognostic factors in stage I gastric cancer: A retrospective analysis.Open Med (Wars)2020https://conductscience.org/library/papers/33336033PubMed
430543589Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives.Clin Adv Hematol Oncol2018https://conductscience.org/library/papers/30543589PubMed
521444866Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.J Clin Oncol2011https://conductscience.org/library/papers/21444866PubMed
634838393Lymph node micrometastasis of poorly differentiated node-negative gastric cancer risks a worse-than-expected survival outcome under standard management algorithm.Eur J Surg Oncol2022https://conductscience.org/library/papers/34838393PubMed
730404528Clinicopathologic factors associated with recurrence and long-term survival in node-negative advanced gastric cancer patients.Rev Esp Enferm Dig2019https://conductscience.org/library/papers/30404528PubMed
816822992Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.N Engl J Med2006https://conductscience.org/library/papers/16822992PubMed
922226517Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.Lancet2012https://conductscience.org/library/papers/22226517PubMed
1034075484Lymphovascular Invasion: Traditional but Vital and Sensible Prognostic Factor in Early Gastric Cancer.Ann Surg Oncol2021https://conductscience.org/library/papers/34075484PubMed
1134019698
Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group.
Int J Cancer2021https://conductscience.org/library/papers/34019698PubMed
1220409751Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.Lancet Oncol2010https://conductscience.org/library/papers/20409751PubMed
1339566657A comprehensive overview of gastric cancer management from a surgical point of view.Biomed J2025https://conductscience.org/library/papers/39566657PubMed
1435969830
Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study.
J Clin Oncol2023https://conductscience.org/library/papers/35969830PubMed
1536342574Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition).Gastric Cancer2023https://conductscience.org/library/papers/36342574PubMed
1633538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
1727090793Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United States.Ann Surg Oncol2016https://conductscience.org/library/papers/27090793PubMed
1839822170Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline).J Gastric Cancer2025https://conductscience.org/library/papers/39822170PubMed
1930903518Implication of lymph node staging in migration and different treatment strategies for stage T2N0M0 and T1N1M0 resected gastric cancer: a SEER population analysis.Clin Transl Oncol2019https://conductscience.org/library/papers/30903518PubMed
2033024588Prognostic Factors in Stage IB Gastric Cancer after Surgical Resection.J Gastric Cancer2020https://conductscience.org/library/papers/33024588PubMed

See all 29 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41999560

GET https://conductscience.org/api/papers/v1/41999560/references?page=2